Timed Release Melatonin Plus¿ with Vitamin B6
Natural health product licensed in Canada
- Licence holder
- Exzell Pharma Inc.
- NPN or DIN-HM
- 80005067
- Status
- Inactive licence
- Licence date
- 7 February 2008
- Revision date
- 15 August 2018
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| N-[2-(5-méthoxyindol-3-yl)éthyl] acétamide Source : N-[2-(5-Methoxyindol-3-yl) ethyl] acetamide | 3 mg | Not calculated |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 25 mg | Not calculated |
Non-medicinal ingredients
Cellulose - microcrystalline, phosphate de dicalcium, Stéarate de magnésium, Dioxyde de silicium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | Not specified |
Uses authorised in Canada
Helps restore the body's natural sleep cycle associated whit the circadian rhythm & helps relieve the daytime fatigue associated with jet lag. It also helps improve sleep quality by increasing total sleep time in people suffering from sleep time in people suffering from sleep restriction or an altered sleep schedule, such as shift-work, and helps reduce time taken to fall asleep in people with delayed sleep phase syndrome.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult healthcare practitioner prior to use if you have a hommonal disorder, diabetes, liver or kidney disease, cerebral palsy, seizure disorders, migraine, depression and/ or hypertension or if you are taking blood pressure or sedative/hypnotic medications. If symptoms persist continuously for more than 4 weeks, or if pain or other factors appear to be the cause of sleeplessness, consult your healthcare practitioner. Do not drive or use machinery for 5 hours after taking melatonin.
- Contre-indications
Do not use if pregnant/breast feeding and/or if you are taking immunosuppressive drugs.
Source
Official Health Canada record, licence 80005067
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging